Monday, 19 October 2015

Some peptide for IDH1 mutant tumors

http://www.nature.com/scibx/journal/v7/n29/full/scibx.2014.851.html
Posted by at
Labels: ,

1 comment:

  1. Stephen W19 October 2015 at 10:48

    This vaccine is now in clinical trial in Germany, for newly diagnosed IDH1-mutant high grade glioma.

    https://www.clinicaltrials.gov/ct2/show/NCT02454634

    At trial at Duke for recurrent grade 2 glioma not yet recruiting.

    https://clinicaltrials.gov/ct2/show/NCT02193347

    ReplyDelete

Subscribe to: Post Comments (Atom)